Edition:
United Kingdom

Crinetics Pharmaceuticals Inc (CRNX.OQ)

CRNX.OQ on NASDAQ Stock Exchange Global Select Market

23.00USD
16 Oct 2018
Change (% chg)

$0.15 (+0.66%)
Prev Close
$22.85
Open
$23.05
Day's High
$23.05
Day's Low
$22.16
Volume
2,433
Avg. Vol
--
52-wk High
$40.78
52-wk Low
$19.25

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.66 -0.232
Mar '18 0.44 -0.248
FY 2017 Dec '17
Jun '17 0.83 -0.075
Mar '17 0.05 -0.118
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 3 0.17 0.30 0.00 --
Quarter Ending Mar-19 2 0.25 0.40 0.10 --
Year Ending Dec-18 3 1.70 2.00 1.50 --
Year Ending Dec-19 3 0.30 0.50 0.00 --
Earnings (per share)
Quarter Ending Dec-18 3 -0.39 -0.35 -0.44 --
Quarter Ending Mar-19 3 -0.37 -0.35 -0.39 --
Year Ending Dec-18 3 -2.01 -1.78 -2.31 --
Year Ending Dec-19 3 -1.79 -1.70 -1.94 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 86.20 32.69
P/E High - Last 5 Yrs. -- 290.01 45.21
P/E Low - Last 5 Yrs. -- 90.56 23.82
Beta -- 0.93 0.88
Price to Sales (TTM) -- 123.88 5.82
Price to Book (MRQ) -- 15.34 4.90
Price to Tangible Book (MRQ) -- 14.54 6.53
Price to Cash Flow (TTM) -- 70.75 22.98
% Owned Institutions -- 13.94 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.34 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.56 5.38
Payout Ratio(TTM) -- 16.91 43.96

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 391.55 7.73
Sales (TTM) vs TTM 1 Yr. Ago -- 73.89 5.32
Sales - 5 Yr. Growth Rate -- 30.83 9.89
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 24.83 22.57
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 37.95 10.95
Capital Spending - 5 Yr. Growth Rate -- 38.70 14.94

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.94 2.25
Current Ratio (MRQ) -- 5.32 3.05
LT Debt to Equity (MRQ) -- 35.04 12.63
Total Debt to Equity (MRQ) -- 36.85 16.96
Interest Coverage (TTM) -- -97.99 37.54

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.92
Gross Margin - 5 Yr. Avg. -- 49.23 52.45
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -574.53 11.10
Operating Margin (TTM) -- -770.03 4.36
Operating Margin - 5 Yr. Avg. -- -594.78 6.45
Pre-Tax Margin (TTM) -- -731.81 5.41
Pre-Tax Margin - 5 Yr. Avg. -- -600.11 6.89
Net Profit Margin (TTM) -- -732.73 1.68
Net Profit Margin - 5 Yr. Avg. -- -603.07 3.14
Effective Tax Rate (TTM) -- 23.70 23.23
Effective Tax Rate - 5 Yr. Avg. -- 18.84 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,887,281 812,879,200
Net Income/Employee (TTM) -- 1,727,321 95,609,515
Receivable Turnover (TTM) -- 19.88 5.78
Inventory Turnover (TTM) -- 2.39 3.60
Asset Turnover (TTM) -- 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -0.96 10.94
Return on Assets - 5 Yr. Avg. -- 3.30 12.05
Return on Investment (TTM) -- 0.73 14.32
Return on Investment - 5 Yr. Avg. -- 2.37 15.66
Return on Equity (TTM) -- 1.82 16.04
Return on Equity - 5 Yr. Avg. -- 3.23 16.92

Performance for Crinetics Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -- -- -- 60
13 Week -- -- -- 64
26 Week -- -- -- 77
52 Week -- -- -- 47
YTD -- -- -- 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 79.97%
# of Holders: 16
Total Shares Held: 19,211,001
3 Mo. Net Change: 4,443,719
# New Positions: 10
# Closed Positions: 0
# Increased Positions: 14
# Reduced Positions: 0
# Net Buyers: 14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.